Femasys Inc
NASDAQ:FEMY

Watchlist Manager
Femasys Inc Logo
Femasys Inc
NASDAQ:FEMY
Watchlist
Price: 0.4824 USD -3.15% Market Closed
Market Cap: $28.2m

Femasys Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Femasys Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Femasys Inc
NASDAQ:FEMY
Other Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Other Items
-$1.8B
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Edwards Lifesciences Corp
NYSE:EW
Other Items
-$452.7m
CAGR 3-Years
N/A
CAGR 5-Years
-30%
CAGR 10-Years
-8%
Stryker Corp
NYSE:SYK
Other Items
-$4.1B
CAGR 3-Years
-21%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Other Items
-$251m
CAGR 3-Years
N/A
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Other Items
$1.2B
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Femasys Inc
Glance View

Market Cap
28.2m USD
Industry
Health Care

Femasys, Inc. operates as a medical device company that focuses on women's healthcare. The company is headquartered in Suwanee, Georgia. The company went IPO on 2021-06-18. The firm is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics. The firm has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. FemaSeed is an artificial insemination infertility treatment. The firm also offers FemVue Saline-Air device for diagnosis of infertility and FemCerv Endocervical Sampler for diagnosis of cervical cancer. FemCerv is a sterile, single-use disposable endocervical curettage product that can be used to sample cervical cells and tissue, including in support of further testing following an abnormal Pap test to assess for any problems such as cancer, in a relatively pain-free office procedure.

FEMY Intrinsic Value
0.8248 USD
Undervaluation 42%
Intrinsic Value
Price

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett